This Article Full Text Free Full Text (PDF) Free All Versions of this Article: chest.06-2756v1 131/6/1718    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Elizur, A. Articles by Cannon, C. L. Search for Related Content PubMed PubMed Citation Articles by Elizur, A. Articles by Cannon, C. L.

Panton-Valentine Leukocidin-Positive Methicillin-Resistant Staphylococcus aureus Lung Infection in Patients With Cystic Fibrosis^*

^* From the Departments of Pediatrics (Drs. Elizur, Orscheln, Ferkol, Buller, Storch, and Cannon), Medicine (Dr. Atkinson), and Pathology and Immunology (Dr. Dunne), and the Genome Sequencing Center (Mr. Armstrong and Dr. Mardis), Washington University School of Medicine, St. Louis, MO.

Correspondence to: Arnon Elizur, MD, Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, Campus Box 8116, 660 S Euclid Ave, Saint Louis, MO 63110; e-mail: Elizur_A{at}kids.wustl.edu

Abstract

Background: Panton-Valentine Leukocidin-expressing (PVL⁺) methicillin-resistant Staphylococcus aureus (MRSA) is an emerging pathogen worldwide causing fatal necrotizing pneumonias in otherwise healthy individuals but has not been described in patients with cystic fibrosis (CF). Following two cases of patients with CF admitted with lung abscesses in association with PVL⁺ MRSA, we examined the incidence and the clinical characteristics of MRSA acquisition in our CF patient population.

Methods: Newly acquired MRSA isolates from patients with CF followed up at St. Louis Children’s Hospital were analyzed for the presence of Panton-Valentine leukocidin coding region, clindamycin susceptibility, staphylococcal cassette chromosome (SCC) mec type, and multilocus sequence type. Medical records and pulmonary function studies at the time of MRSA isolation were reviewed.

Results: MRSA isolates from 40 CF patients were available for analysis. Six children (15%) had PVL⁺ MRSA infection. All PVL⁺ organisms were clindamycin susceptible. Patients who acquired a PVL⁺ organism were more likely to have a focal pulmonary infiltrate on chest radiograph, including cavitary lung lesions in two patients (p = 0.04), a markedly greater decline in FEV₁ at the time of MRSA detection (p = 0.01), and a significantly higher WBC count (p = 0.04) and absolute neutrophil count (p = 0.04). These patients were more likely to be admitted for IV antibiotic therapy for respiratory illnesses (p < 0.01).

Conclusions: We describe the emergence of PVL⁺ MRSA in our CF population in association with development of invasive lung infections including lung abscesses. Early identification and treatment of CF patients with newly acquired PVL⁺ MRSA may be crucial.

Key Words: cystic fibrosis • lung abscess • Staphylococcus aureus

This article has been cited by other articles:

				D. Glikman, J. D. Siegel, M. Z. David, N. M. Okoro, S. Boyle-Vavra, M. L. Dowell, and R. S. Daum Complex Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolates From Children With Cystic Fibrosis in the Era of Epidemic Community-Associated Methicillin-Resistant S aureus Chest, June 1, 2008; 133(6): 1381 - 1387. [Abstract] [Full Text] [PDF]